Today is the first day of National Diabetes Awareness Month, and to mark the occasion, we had a conversation with three college students, Hannah, ...
Continue readingAccelerating clinical studies is a mission that affects us all.
Today is the first day of National Diabetes Awareness Month, and to mark the occasion, we had a conversation with three college students, Hannah, ...
Continue readingOne of the most important results of the work we do at Antidote is directly impacting the lives of patients — and getting to hear their stories is a ...
Continue readingWe interviewed Alice Bast, CEO of Beyond Celiac, about her organization and what's next for celiac disease research.
Continue readingWhat is Mild Cognitive Impairment? Mild cognitive impairment (MCI) causes slight but noticeable memory changes and thinking problems. These thinking ...
Continue readingThough asthma is a condition that impacts an estimated 27 million Americans, the experience each individual has with it is unique. Depending on the ...
Continue readingOur friends at Us Against Alzheimer’s recently announced that 27 Phase III and 8 Phase II Alzheimer’s disease drugs appear on track to launch in the ...
Continue readingLiving with rare diseases can be exceptionally challenging, and patients often must deal with years of misdiagnosis on their journey. A common ...
Continue readingOne year ago, JDRF launched Antidote Match on the Clinical Trials Connection page. To mark the occasion, we sat down with our two main collaborators, ...
Continue readingLupus Research Alliance, a member of the Antidote partnership network, is dedicated to finding better treatments and ultimately preventing and curing ...
Continue reading